$KYMR
Kymera Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is KYMR down today? It is at $104.00 (-1.40%), and our scanner flagged it 19 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KYMR spikes, and full due diligence on KYMR — key stats, earnings, dilution and insider activity. Free.
Get free $KYMR alerts the moment volume spikes
Our scanner flagged $KYMR 19 times in the last 30 days. Create a free account to track $KYMR, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $104.00
- Change today
- -1.40%
- Previous close
- $105.48
- 52-week range
- $36.65 – $130.05
- Market cap
- $8.77B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 9.9M ▼ -2% vs prior · as of 2026-07-15
- Days to cover
- 14.7d
- Avg daily volume
- 802K
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 1.2x
- 15m
- 2.5x
- 1h
- 1.0x
- 1D
- 0.1x
Get free KYMR + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $KYMR down today?
KYMR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on KYMR today, peaking at 3.4x its normal volume. Fresh from the SEC: Kymera Therapeutics, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Smart money in $KYMR
All smart money →- FAFisher Asset Management (Fisher) opened a new positionAs of Q2 2026 holdings · filed Aug 4, 2026$1M13F-HR ↗
From SEC 13F quarterly holdings (position as of quarter-end, not a transaction date or price) and dated 13D/13G stake filings. Not investment advice.
Insiders
1 buys, 24 sells last 3 months (8/69 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Rooney Terence Officer | Acquired (grant/award) | +38K 0.05% of company | n/a | 38K | n/a | Jul 27, 26 |
Mainolfi Nello Officer | Sold (automatic/other) | -50K 0.06% of company | sold 7.0% | 667K | $6.0M at $119.00 | Jul 7, 26 |
Mainolfi Nello Officer | Other | 50K 0.06% of company | added 7.5% | 717K | $104K at $2.08 | Jul 7, 26 |
Goodman Noah Officer | Sold (automatic/other) | -3K | sold 6.7% | 47K | $387K at $114.29 | Jul 1, 26 |
Mainolfi Nello Officer | Sold (automatic/other) | -80K 0.10% of company | sold 11% | 667K | $9.0M at $112.80 | Jul 1, 26 |
Mainolfi Nello Officer | Other | 80K 0.10% of company | added 12% | 747K | $166K at $2.08 | Jul 1, 26 |
Jacobs Bruce N. Officer | Sold (automatic/other) | -77K 0.09% of company | sold 24% | 245K | $8.5M at $110.54 | Jun 30, 26 |
Jacobs Bruce N. Officer | Other | 61K 0.07% of company | added 24% | 322K | $327K at $5.33 | Jun 30, 26 |
Booth Bruce Director | Sold (automatic/other) | -45K 0.05% of company | sold 1.6% | 2.88M | $4.8M at $105.78 | Jun 29, 26 |
Booth Bruce Director | Sold (automatic/other) | -31K 0.04% of company | sold 1.1% | 2.85M | $3.4M at $108.28 | Jun 29, 26 |
Bvf Partners L P/Il Director | Sold (automatic/other) | -1.58M 1.9% of company | sold 87% | 240K | $168.1M at $106.50 | Jun 26, 26 |
Bvf Partners L P/Il Director | Sold (automatic/other) | -52K 0.06% of company | sold 40% | 79K | $5.5M at $106.50 | Jun 26, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $KYMR runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $500M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$KYMR Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$KYMR Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to KYMR
Comparable names in biological products, (no diagnostic substances), closest in size first.
KYMR stock FAQ
Why is $KYMR down today?
KYMR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on KYMR today, peaking at 3.4x its normal volume. Fresh from the SEC: Kymera Therapeutics, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
What is the KYMR stock price today?
KYMR last traded at $104.00, down 1.40% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live KYMR alerts?
The KYMR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KYMR 19 times in the last 30 days.
What exchange is KYMR on?
KYMR (Kymera Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $8.77B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is KYMR good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KYMR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.